Scott P Owen (Scott Owen)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Small Cell Lung Cancer

Placebo Controlled

Renal Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Neuro-oncology advances

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Luis G Paz-Ares, Oscar Juan Vidal, Giannis S Mountzios, Enriqueta Felip Font, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M Patel, Takayuki Takahama, Scott P Owen, Douglas M Reznick, Firas B Badin, Irfan Cicin, Sabeen Mekan, Riddhi Patel, Eric Zhang, Divyadeep Karumanchi, Marina-Chiara Garassino
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mame Daro Faye, Jacob Easaw, Paula De Robles, Raman Agnihotram, Alexander Torres-Vasquez, Frederic Lamonde, Kevin Petrecca, Scott P Owen, Valerie Panet-Raymond, George Shenouda, Luis Souhami, Maryam Azam, Bushra Hossain, Jad Alkass, Siham Sabri, Bassam Abdulkarim
Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma. Neuro-oncology advances 5 (1) (2023)
Philip Wong, Laura Masucci, Marie Florescu, Marc-Emile Plourde, Valerie Panet-Raymond, Michel Pavic, Scott P Owen, Laurence Masson-Coté, Cynthia Ménard, Bertrand Routy, Mustapha Tehfé, Kristoff Nelson, François Guilbert, Olivier Boucher, Sareh Keshavarzi, Normand Blais, David Roberge
Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases. Neuro-oncology advances 5 (1) (2023)
Andréanne Leblanc, Scott P Owen, Pierre-Olivier Fiset, Andrea Liliam Gomez Corrador, Jordan Isenberg, Nathaniel Bouganim
Metastatic Large-Cell Neuroendocrine Lung Carcinoma With ALK Fusion Oncogene With Partial Response to Alectinib. JCO precision oncology 5 (2022)